UBC is playing a key role in understanding and preventing chronic diseases like diabetes and arthritis. With a commitment to evidence-based practice, our researchers are generating new knowledge that is reshaping how we treat and manage complex diseases.
Skip to Stories
Discoveries
Spotlight
UBC researchers seek participants for spinal cord injury study
Dr. Andrei Krassioukov explains the purpose of the study and how eligible patients can get involved.
Read more >
Specialized immune cells could help repair damage from inflammatory bowel disease in children
A type of T cell produces a chemical signal that helps repair the barrier formed by cells lining the gut.
Read more >
Too many Canadians live with multiple chronic conditions
Greater efforts to improve lifestyle identified as a solution.
Read more >
UBC study holds promise for novel and safe treatment for Type 2 diabetes
Reducing a protein in the fat cells of mice not only prevents onset of Type 2 diabetes but also appears to reverse the disease.
Read more >
Kids with harder to manage diabetes improve the most from insulin pumps
New research led by Brenden Hursh suggests clinicians may need to rethink which children are offered this treatment.
Read more >
Jacquelyn Cragg receives L’Oréal-UNESCO award for women in science
Dr. Cragg, a neuro-epidemiologist, is only the third Canadian to ever win this prestigious award.
Read more >
New protein “switch” could be key to controlling blood-poisoning and preventing death
The discovery opens up the potential for new treatments for chronic and acute inflammatory diseases, as well as auto-immune diseases.
Read more >
Scientists grow perfect human blood vessels in a petri dish
Breakthrough technology advances research of vascular diseases like diabetes.
Read more >
UBC expands research into healthy aging with $24 million gift
The donation from Edwin S.H. Leong is the largest gift that the Faculty of Medicine has ever received from an individual.
Read more >
UBC Medicine receives 40% of national genomics funding
The 10 projects, totaling $101 million, include an effort to reduce the risk of kidney transplant rejection.
Read more >